Common use of Authorization of Notes Clause in Contracts

Authorization of Notes. The Company will authorize the issue and sale of US$25,000,000.00 aggregate principal amount of its Senior Secured Notes due July 25, 2009 (the "Notes", such term to include any such notes issued in substitution therefore pursuant to Section 14 of this Agreement). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by you and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "Schedule" or an "Exhibit" are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize the issue and sale of US$25,000,000.00 $50,000,000 aggregate principal amount of its 7.75% Senior Secured Notes due July 25September 17, 2009 2017 (as amended, restated, supplemented or otherwise modified from time to time, the "“Notes"”, such term to include any such notes issued in substitution therefore therefor pursuant to Section 14 of this Agreement13). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by you and the Company. A. Certain capitalized and other terms used in this Agreement are defined in Schedule B; and references to a "“Section”, “Schedule" ” or an "“Exhibit" ” are, unless otherwise specified, to a Section, Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize the issue and sale of US$25,000,000.00 $50,000,000 aggregate principal amount of its 7.86% Senior Secured Notes due July 25August 1, 2009 2011 (the "Notes", such term to include any such notes issued in substitution therefore therefor pursuant to Section 14 13 of this Agreement). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by you and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "Schedule" or an "Exhibit" are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize the issue and sale of US$25,000,000.00 $60,000,000 aggregate principal amount of its 4.42% Senior Secured Guaranteed Notes due July 2528, 2009 2028 (the "“Notes", ,” such term to include any such notes issued in substitution therefore pursuant to Section 14 of this Agreement13). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by you the Purchasers and the Company. Certain capitalized and other terms used in this Agreement are defined in Schedule B; and references to a "“Schedule" ” or an "“Exhibit" ” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize the issue and sale of US$25,000,000.00 €125,000,000 aggregate principal amount of its 1.47% Senior Secured Notes due July 25June 17, 2009 2030 (the "“Notes", ,” such term to include any such notes issued in substitution therefore therefor pursuant to Section 14 of this Agreement13). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by you the Purchasers and the Company. Certain capitalized and other terms used in this Agreement are defined in Schedule B; and references to a "“Schedule" ” or an "“Exhibit" ” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize the issue and sale of US$25,000,000.00 $100,000,000 aggregate principal amount of its 4.50% Series G Senior Secured Notes due July 25February 16, 2009 2032 (as amended, amended and restated, supplemented or otherwise modified from time to time, the "“Notes"”, such term to include any such notes issued in substitution therefore therefor pursuant to Section 14 13 of this Agreement). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by you and the Company. A. Certain capitalized and other terms used in this Agreement are defined in Schedule B; and references to a "“Schedule" ” or an "“Exhibit" ” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize the issue issuance and sale of US$25,000,000.00 $85,800,000 aggregate principal amount of its 5.03% Senior Secured Notes due July 2519, 2009 2024 (as amended, restated, supplemented or otherwise modified from time to time, the "“Notes"”, such term to include any such notes issued in substitution therefore therefor pursuant to Section 14 of this Agreement13). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by you and the Company. Certain capitalized and other terms used in this Agreement are defined in Schedule B; and references to a "“Schedule" ” or an "“Exhibit" ” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize the issue and sale of US$25,000,000.00 $37,500,000 aggregate principal amount of its 12% Senior Secured Notes due July 25[_________], 2009 2001 (the "Notes", such term to include any such notes issued in substitution therefore therefor pursuant to Section 14 of this Agreement). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by you and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "Schedule" or an "Exhibit" are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize the issue and sale of US$25,000,000.00 $125,000,000 aggregate principal amount of its 4.47% Senior Secured Guaranteed Notes due July 25October 30, 2009 2031 (the "“Notes"”, such term to include any such notes issued in substitution therefore pursuant to Section 14 of this Agreement13). The Notes shall be substantially in the form set out in Exhibit 1, 1 with such changes therefrom, if any, as may be approved by you the Purchasers and the Company. Certain capitalized and other terms used in this Agreement are defined in Schedule B; and references to a "“Schedule" ” or an "“Exhibit" ” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize the issue and sale of US$25,000,000.00 $20,000,000 aggregate principal amount of its 7.00% Senior Secured Notes due July 25December 30, 2009 2006 (the "NotesNOTES", such term to include any such notes issued in substitution therefore therefor pursuant to Section 14 13 of this Agreement). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by you and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "Schedule" or an "Exhibit" are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize the issue issuance and sale of US$25,000,000.00 $250,000,000 aggregate principal amount of its 4.31% Senior Secured Notes due July 252024 (as amended, 2009 (restated, supplemented or otherwise modified from time to time, the "“Notes"”, such term to include any such notes issued in substitution therefore therefor pursuant to Section 14 of this Agreement14). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by you and the Company. Certain capitalized and other terms used in this Agreement are defined in Schedule B; and references to a "“Schedule" ” or an "“Exhibit" ” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize the issue and sale of US$25,000,000.00 $100,000,000 aggregate principal amount of its 7.49% Senior Secured Notes due July 25November 30, 2009 2006 (the "Notes", ," such term to include any such notes issued in substitution therefore therefor pursuant to Section 14 13 of this Agreement). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by you the Purchasers and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "Schedule" or an "Exhibit" are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize the issue and sale of US$25,000,000.00 $60,000,000 aggregate principal amount of its 4.77% Senior Secured Notes due July 25March 15, 2009 2014 (the "Notes", ," such term to include any such notes issued in substitution therefore therefor pursuant to Section 14 13 of this Agreement). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by you the Purchasers and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "Schedule" or an "Exhibit" are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize the issue and sale of US$25,000,000.00 $25,000,000 aggregate principal amount of its 7.93% Senior Secured Notes due July 25December 27, 2009 2004 (the "Notes", ," such term to include any such notes issued in substitution therefore therefor pursuant to Section 14 13 of this Agreement). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by you and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "Schedule" or an "Exhibit" are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize the issue and sale of US$25,000,000.00 $15,000,000 aggregate principal amount of its 6.90% Senior Secured Notes due July 25, 2009 2010 (the "Notes", such term to include any such notes issued in substitution therefore therefor pursuant to Section 14 13 of this Agreement). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by you and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "Schedule" or an "Exhibit" are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize the issue and sale of US$25,000,000.00 $20,000,000 aggregate principal amount of its 6.09% Senior Secured Notes due July 25December 20, 2009 2012 (the "Notes", such term to include any such notes issued in substitution therefore therefor pursuant to Section 14 13 of this Agreement). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by you and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "Schedule" or an "Exhibit" are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize the issue and sale of US$25,000,000.00 up to $5,000,000 aggregate principal amount of its Senior Secured Notes due July 25May 1, 2009 2008 (the "“Notes"”, such term to include any such notes issued in substitution therefore therefor pursuant to Section 14 13 of this Agreement). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved in writing by you and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "“Schedule" ” or an "“Exhibit" ” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize has authorized the issue and sale of US$25,000,000.00 $80,000,000 aggregate principal amount of its 7.89% Senior Secured Notes Notes, Series A, due July 25May 15, 2009 2010 (the "Notes", such term to include any such notes issued in substitution therefore therefor pursuant to Section 14 13 of this Agreement). The Notes shall will be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by you and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "Schedule" or an "Exhibit" are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize the issue issuance and sale of US$25,000,000.00 up to $1,500,000 aggregate principal amount of its 10% Senior Secured Convertible Notes due July 2531, 2009 1995 (the "NotesNOTES", such term to include any such notes issued in substitution therefore therefor pursuant to Section 14 of this Agreement). The Notes shall section 12) to be substantially in the form of the Notes set out in Exhibit 1A, with such changes --------- therefrom, if any, as may be approved by you and the Company. Certain capitalized terms used in this Agreement are defined in Schedule Bsection 13; references to a "Schedule" or an "Exhibit" are, are unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize the issue and sale of US$25,000,000.00 U.S. $400,000,000 aggregate principal amount of its Senior Secured Subordinated Notes due July 25January 27, 2009 2010 (the "NotesNOTES", such term to include any such notes issued in substitution therefore therefor pursuant to Section 14 11 of this Agreement). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by you and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "Schedule" or an "Exhibit" are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement. 2.

Authorization of Notes. The Company will authorize the issue and sale of US$25,000,000.00 $100,000,000 aggregate principal amount of its 4.19% Senior Secured Guaranteed Notes due July 25September 20, 2009 2029 (the "“Notes"”), such term to include any such notes issued in substitution therefore pursuant to Section 14 of this Agreement13). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by you the Purchasers and the Company. Certain capitalized and other terms used in this Agreement are defined in Schedule B; and references to a "“Schedule" ” or an "“Exhibit" ” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize the issue and sale of US$25,000,000.00 $30,000,000 aggregate principal amount of its 6.86% Senior Secured Notes due July 25September 1, 2009 2015 (the "Notes", such term to include any such notes issued in substitution therefore therefor pursuant to Section 14 13 of this Agreement). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by you each Purchaser and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "Schedule" or an "Exhibit" are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize the issue and sale of US$25,000,000.00 $50,000,000 aggregate principal amount of its 7.27% Senior Secured Notes due July 25Notes, Due 2009 (the "NotesNOTES", such term to include any such notes issued in substitution therefore therefor pursuant to Section 14 13 of this Agreement). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by you each Purchaser and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "Schedule" or an "Exhibit" are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize the issue and sale of US$25,000,000.00 $75,000,000 aggregate principal amount of its 3.68% Senior Secured Notes due July 25November 15, 2009 2025 (the "“Notes"”, such term to include any such notes as amended, restated or otherwise modified from time to time pursuant to Section 17 and any such notes issued in substitution therefore therefor pursuant to Section 14 of this Agreement13). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by you and the Company. Certain capitalized and other terms used in this Agreement are defined in Schedule B; and references to a "“Schedule" ” or an "“Exhibit" ” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize the issue and sale of US$25,000,000.00 $2,020,000 aggregate principal amount of its Increasing Rate Senior Secured Notes due July 25May 26, 2009 2008 (the "Notes", such term to include any such notes issued in substitution therefore therefor pursuant to Section 14 13 of this Agreement). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved in writing by you and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "Schedule" or an "Exhibit" are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize has authorized the issue issuance and sale of US$25,000,000.00 $14,950,000 aggregate principal amount of its 13.75% Senior Secured Notes due July 25, 2009 2026 (the "“Notes", such term to include any such notes issued in substitution therefore ”) pursuant to Section 14 this Note Exchange Agreement (this “Agreement”). The Notes will not be registered under the Securities Act of this Agreement1933, as amended (the “Securities Act”). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by you and the Company. Certain capitalized terms used in this Agreement are defined in Schedule BA; references to an “Annex,” a "“Schedule" ” or an "“Exhibit" ” are, unless otherwise specified, to an Annex, a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize the issue and sale of US$25,000,000.00 $135,000,000 aggregate principal amount of its 4.87% Senior Secured Notes due July 2531, 2009 2023 (the "Notes", ; such term to shall also include any such notes issued in substitution therefore therefor pursuant to Section 14 13 of this Agreement). The Notes shall be substantially in the form forms set out in Exhibit 1, 1 with such changes therefrom, if any, as may be approved by you the Purchasers and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "Schedule" or an "Exhibit" are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize has authorized the issue and sale of US$25,000,000.00 $569,000,000 aggregate principal amount of its 5.22% Senior Secured Notes due July 25August 9, 2009 2020 (the "“Notes"”, such term to include any such notes issued in substitution therefore therefor pursuant to Section 14 13 of this Agreement). The Notes shall will be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by you and the Company. Certain capitalized and other terms used in this Agreement are defined in Schedule B; references to a "“Schedule" ” or an "“Exhibit" ” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize the issue and sale of US$25,000,000.00 $125,000,000 aggregate principal amount of its 5.60% Senior Secured Notes due July 25May 15, 2009 2018 (the "“Notes", ,” such term to include any such notes issued in substitution therefore therefor pursuant to Section 14 13 of this Agreement). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by you the Purchasers and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "“Schedule" ” or an "“Exhibit" ” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize has authorized the issue and sale of US$25,000,000.00 $150,000,000 aggregate principal amount of its 5.24% Senior Secured Notes due July 25April 29, 2009 2011 (the "“Notes"”, such term to include any such notes issued in substitution therefore therefor pursuant to Section 14 13 of this Agreement). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by you and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "“Schedule" ” or an "“Exhibit" ” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.